Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ahmed Aburahma"'
Autor:
Aleezay Asghar, Benjamin Barnes, Ahmed Aburahma, Sabiha Khan, Gabriella Primera, Nakul Ravikumar
Publikováno v:
Epilepsy & Behavior Reports, Vol 21, Iss , Pp 100589- (2023)
Post hypoxic myoclonus (PHM) is considered a poor prognostic sign and may influence decisions regarding withdrawal of treatment. PHM is generally categorized in literature as either acute or chronic (also commonly referred to as Lance-Adams Syndrome)
Externí odkaz:
https://doaj.org/article/dc4f230ff076402ca3495d612aa97094
Autor:
Mahmoud Barbarawi, Babikir Kheiri, Yazan Zayed, Ahmed Aburahma, Mohammed Osman, Owais Barbarawi, Michael Hicks, Mustafa Hassan, Mohammad L. Alkotob, Ghassan Bachuwa
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 9, Iss 1, Pp 9-17 (2019)
Background: Drug-eluting stent(DES) implantation is the main interventional treatment for coronary artery disease, and dual antiplatelet therapy(DAPT) remains the gold standard strategy to prevent ischemic events. However, the optimal duration of DAP
Externí odkaz:
https://doaj.org/article/be6c817f74ab45b3824db4427bfa45eb
Autor:
Mahmoud Barbarawi, Ahmed Aburahma, Yazan Zayed, Mohammed Osman, Laith Rashdan, Bakr Swaid, Ghassan Bachuwa
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 8, Iss 6, Pp 349-356 (2018)
Background: Diabetes is a very common cause of cardiovascular disease, and metformin remains the first-line treatment of diabetes. Many trials were conducted to prove the efficacy and safety of other antidiabetic medication as the best add-on medicat
Externí odkaz:
https://doaj.org/article/a4b1555b8fe84ac5b9e91e8ed53c8651
Autor:
Yanal Alnimer, Ranine Ghamrawi, Ahmed Aburahma, Samer Salah, Carlos Rios-Bedoya, Khalil Katato
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 7, Iss 6, Pp 341-346 (2017)
Background: Several factors could affect disease recurrence in surgically resected colon cancer. While the role of certain factors such as cancer stage and grade is well established, the role of other factors (e.g., histological subtypes) is yet to b
Externí odkaz:
https://doaj.org/article/49dae33774e846a0bf0620c13dce2c80
Publikováno v:
Case Reports in Hematology, Vol 2018 (2018)
Nivolumab is a monoclonal antibody against the programmed death protein 1 and is used for patients with advanced melanoma. It is associated with potentially immune-related adverse events, including disorders of the skin, GI tract, and the thyroid; th
Externí odkaz:
https://doaj.org/article/af3f43ca7e6f480280ac4ea5823ce7fd
Autor:
Mohamed Abdel Rahman, Hala Madkour, Fatma El-saeed El-Demerdash, Hala Mahfouz, Abdelrahman Ahmed Aburahma, Sarah Mosaad Amer
Publikováno v:
Egyptian Journal of Histology.
Publikováno v:
Critical Care Medicine. 51:428-428
Autor:
Bakr Swaid, Yazan Zayed, Ghassan Bachuwa, Mahmoud Barbarawi, Ahmed Aburahma, Mohammed Osman, Laith Rashdan
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 8, Iss 6, Pp 349-356 (2018)
Journal of Community Hospital Internal Medicine Perspectives
Journal of Community Hospital Internal Medicine Perspectives
Background: Diabetes is a very common cause of cardiovascular disease, and metformin remains the first-line treatment of diabetes. Many trials were conducted to prove the efficacy and safety of other antidiabetic medication as the best add-on medicat
Autor:
Michael Hicks, Ghassan Bachuwa, Kewan Hamid, Babikir Kheiri, Ahmed Aburahma, Yazan Zayed, Arul Chandran, Momen Banifadel
Publikováno v:
Journal of Asthma. 56:1110-1119
Objective: We aimed to perform a meta-analysis evaluating the efficacy and safety of dupilumab in patients with uncontrolled asthma. Data source: A search of electronic databases was performed usin...
Publikováno v:
Oncology Research and Treatment. 41:226-234
Background: PARP (poly(ADP-ribose) polymerase) inhibitors are used more frequently in platinum-sensitive recurrent ovarian cancer. Methods: We conducted a meta-analysis to check the strength of evidence on the use of PARP inhibitors for relapsed plat